You are here

DDMoRe

The Drug Disease Model Resources (DDMoRe) consortium has been created to improve the quality, efficiency and cost effectiveness of Model-Informed Drug Discovery & Development.

 

A public-private partnership with 27 partners. In model-informed drug development, information from a wide array of sources can be integrated into models to describe and predict the behaviour of complex disease/biological systems and drug actions. The consortium will deliver a platform as resource for models and knowledge sharing, based on standards to ensure consistency of evidence. Academia, industries and health authorities can rely on this platform in making decisions about development, approval of new medicines and improvement of therapy with existing drugs.